BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37877594)

  • 1. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
    Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
    Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists.
    Glewis S; Lingaratnam S; Krishnasamy M; H Martin J; Tie J; Alexander M; Michael M
    J Oncol Pharm Pract; 2024 Jan; 30(1):30-37. PubMed ID: 37021580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing
    Varughese LA; Bhupathiraju M; Hoffecker G; Terek S; Harr M; Hakonarson H; Cambareri C; Marini J; Landgraf J; Chen J; Kanter G; Lau-Min KS; Massa RC; Damjanov N; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
    Front Oncol; 2022; 12():859846. PubMed ID: 35865463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
    Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.
    Jeiziner C; Meyer Zu Schwabedissen HE; Hersberger KE; Allemann SS
    Int J Clin Pharm; 2023 Dec; 45(6):1378-1386. PubMed ID: 37338707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 8. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
    Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
    BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare professionals' and consumers' knowledge, attitudes, perspectives, and education needs in oncology pharmacogenomics: A systematic review.
    Lim CX; Bozkurt A; Chen ZY; Hird A; Wickens J; Lazarakis S; Hussainy SY; Alexander M
    Clin Transl Sci; 2023 Dec; 16(12):2467-2482. PubMed ID: 37991131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
    Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
    Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
    Bank PC; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
    Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
    Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework.
    van der Wouden CH; Paasman E; Teichert M; Crone MR; Guchelaar HJ; Swen JJ
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32192029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.
    Luczak TS; Schillo PJ; Renier CM; Waring SC; Friday BB
    J Oncol Pharm Pract; 2022 Jun; 28(4):842-849. PubMed ID: 33853470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
    Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
    J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation.
    Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL
    Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership.
    Bousman CA; Oomen A; Jessel CD; Tampi RR; Forester BP; Eyre HA; Lavretsky H; Müller DJ
    Am J Geriatr Psychiatry; 2022 May; 30(5):560-571. PubMed ID: 34740522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes toward pharmacogenetics in patients undergoing
    Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
    Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.